
The Global X Nasdaq 100 Tail Risk ETF (QTR) is engineered to replicate the overall financial outcome, covering both value appreciation and income generation, of the Nasdaq-100 Quarterly Protective Put 90 Index, all considered before the fund's own fees and expenses.
Is QTR's expense ratio expensive, average, or a steal for its category?
Pro reveals the verdict on a 5-tier spectrum calibrated against ICI 2025 industry averages, with strategy-aware bands so the comparison is meaningful.

Global X NASDAQ 100 Tail Risk ETF (NASDAQ: QTR - Get Free Report) saw a significant growth in short interest in the month of January. As of January 15th, there was short interest totaling 873 shares, a growth of 19.4% from the December 31st total of 731 shares. Approximately 1.0% of the shares of the company

More than three quarters of S&P 500 companies have already reported fourth quarter earnings, FactSet data shows, and this week Nvidia joined them. The release after market hours on Wednesday was highly anticipated, so here we are, talking about little else.

FORT LAUDERDALE, FL / ACCESSWIRE / August 19, 2024 / Sunshine Biopharma, Inc. (NASDAQ:SBFM) (the "Company"), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas including oncology and antivirals today announced that it has filed its 2024 second quarter report with the Securities and Exchange Commission. The Company reported gross revenues of $9,303,067 for the three months ended June 30, 2024, a 67% increase over gross revenues of $5,560,865 for same period in 2023.

It looks like we are feeling good about markets these days, which are hovering at all-time highs, but not completely confident in what comes next.

ETFs that promise downside protection have important differences that show up in performance.